Table 1.
Compounds | ZIKV | CHIKV | |||
---|---|---|---|---|---|
CC50a(μg or μM) | EC50b(μg or μM) | SIc | EC50b(μg or μM) SIc | ||
Extract | 438 μg/mL ± 5.18 | 2.15 ± 0.22 | 203 | 2.45 ± 1.02 | 178 |
Dolastane | 935 µM/mL ± 11.0 | 0.75 ± 0.18 | 1246 | 1.28 ± 0.47 | 730 |
Ribavirin | 297 μM/mL ± 4.25 | 3.95 ± 0.95 | 75.2 | 2.42 ± 0.49 | 122 |
The mean values ± standard deviations are representative of three independent experiments.
aConcentration required to reduce 50% cell viability when compared to untreated controls.
bConcentration that reduced 50% of ZIKV or CHIKV replication when compared to infected and untreated controls.
cSelectivity index was defined as the ratio between CC50 and EC50.